These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30258071)

  • 1. TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.
    Wang G; Huang W; Li W; Chen S; Chen W; Zhou Y; Peng P; Gu W
    Sci Rep; 2018 Sep; 8(1):14402. PubMed ID: 30258071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
    Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
    J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.
    Wang G; Zeng Y; Chen S; Li D; Li W; Zhou Y; Singer RH; Gu W
    Sci Rep; 2017 Oct; 7(1):13575. PubMed ID: 29051606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2.
    Peng X; Li F; Wang P; Jia S; Sun L; Huo H
    Int J Mol Med; 2015 Sep; 36(3):733-8. PubMed ID: 26135903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
    Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells.
    Chung TW; Choi H; Lee JM; Ha SH; Kwak CH; Abekura F; Park JY; Chang YC; Ha KT; Cho SH; Chang HW; Lee YC; Kim CH
    J Ethnopharmacol; 2017 Jan; 195():309-317. PubMed ID: 27876502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
    Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
    Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
    Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
    Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
    You K; Su F; Liu L; Lv X; Zhang J; Zhang Y; Liu B
    Mol Cell Biochem; 2017 Nov; 435(1-2):47-58. PubMed ID: 28497372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
    Xu Z; Maiti D; Kisiel W; Duh EJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
    Wu Z; Wang T; Fang M; Huang W; Sun Z; Xiao J; Yan W
    Biochem Biophys Res Commun; 2018 Apr; 498(3):495-501. PubMed ID: 29526753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.
    Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D
    BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells.
    Guvakova MA; Adams JC; Boettiger D
    J Cell Sci; 2002 Nov; 115(Pt 21):4149-65. PubMed ID: 12356918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin.
    Liu Z; Zhan Y; Tu Y; Chen K; Liu Z; Wu C
    Oncogene; 2015 Mar; 34(10):1300-11. PubMed ID: 24662836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdependency and differential expression of ERK1 and ERK2 in breast and melanoma cell lines.
    Moulik S; Karmakar S; Basu A; Ali M; Chatterjee A
    J Egypt Natl Canc Inst; 2024 Sep; 36(1):27. PubMed ID: 39278984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
    Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
    Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
    Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
    Bretz N; Noske A; Keller S; Erbe-Hofmann N; Schlange T; Salnikov AV; Moldenhauer G; Kristiansen G; Altevogt P
    Clin Exp Metastasis; 2012 Jan; 29(1):27-38. PubMed ID: 21984372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.